We propose to develop a soluble, DNA carrier system that can target foreign genes specifically to hepatocytes. The idea is based on: 1) The presence of unique cell-surface receptors on hepatocytes that can internalize galactose-terminal (asialo-) glycoproteins 2) polycations can form strong, non-covalent interactions with DNA resulting in the formation of soluble complexes. We hypothesized that chemical coupling of an asialoglycoprotein to a polycation could result in a conjugate that, upon subsequent exposure to DNA could form a soluble complex which then could be targeted specifically to hepatocytes via their asialoglycoprotein receptors. To test the idea, we propose to synthesize various asialoglycoprotein- polycation conjugates and screen them for: 1) DNA binding by an agarose gel retardation system, asialoglycoprotein rector recognition using an in vitro uptake assay, targeted using an assay for CAT enzyme activity in vitro. Conjugates will be tested in normal rats to identify the most effective conjugate for liver-specific targeted gene delivery and expression in vivo. The efficiency of hepatic delivery of intact foreign sequences will be determined by Southern blot; histological distribution of targeted DNA by in situ hybridization, and localization of actual foreign product by immunofluorescence. We determine the time course and examine the effects of enzyme inhibitors and lysosomotropic amines on the efficiency of targeted gene expression. Several methods for stimulation hepatocyte regeneration (partial hepatectomy, CCl4 and nafenopin) will be studied to enhance persistence of targeted gene expression in vivo. Finally, we propose to prepare plasmids containing the human albumin structural gene driven by natural albumin, or viral regulatory elements. Using a mutant (Nagase NAR) strain of rats genetically deficient in the production of serum albumin, the soluble DNA carrier system will be tested for its ability to deliver these plasmids and correct the inherited disorder of metabolism by intravenous injection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042182-04
Application #
3243247
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1990-01-01
Project End
1994-12-31
Budget Start
1993-01-01
Budget End
1993-12-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Medicine
DUNS #
City
Farmington
State
CT
Country
United States
Zip Code
06030
Smolic, Martina; Wu, Catherine H; Madadi, Shilpa et al. (2012) Pharmacogenetic selection of transplanted human hepatocytes in immunocompetent rats. J Dig Dis 13:579-87
Smolic, Robert; Smolic, Martina; Andorfer, John H et al. (2010) Inhibition of hepatitis C virus replication by single-stranded RNA structural mimics. World J Gastroenterol 16:2100-8
Volarevic, Martina; Wu, Catherine H; Smolic, Robert et al. (2007) A novel G418 conjugate results in targeted selection of genetically protected hepatocytes without bystander toxicity. Bioconjug Chem 18:1965-71
Smith, R M; Smolic, R; Volarevic, M et al. (2007) Positional effects and strand preference of RNA interference against hepatitis C virus target sequences. J Viral Hepat 14:194-212
Konishi, Masayoshi; Wu, Catherine H; Kaito, Masahiko et al. (2006) siRNA-resistance in treated HCV replicon cells is correlated with the development of specific HCV mutations. J Viral Hepat 13:756-61
Virovic, Lucija; Wu, Catherine H; Konishi, Masayoshi et al. (2005) Novel delivery methods for treatment of viral hepatitis: an update. Expert Opin Drug Deliv 2:707-17
Wu, George Y; Konishi, Masayoshi; Walton, Cherie M et al. (2005) A novel immunocompetent rat model of HCV infection and hepatitis. Gastroenterology 128:1416-23
Smith, R M; Wu, G Y (2004) Secondary structure and hybridization accessibility of the hepatitis C virus negative strand RNA 5'-terminus. J Viral Hepat 11:115-23
Fukuma, Toshiko; Walton, Cherie M; Wu, Catherine H et al. (2003) Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression. Bioconjug Chem 14:295-301
Konishi, Masayoshi; Wu, Catherine H; Wu, George Y (2003) Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology 38:842-50

Showing the most recent 10 out of 43 publications